Where Tech Meets Bio

Home
State of AI in Bio
Archive
About
An Unnoticed Event That May Symbolize the Future of Drug Testing
ALSO: The new interface of Gen AI for drug discovery; weekly highlights; my favorite pharma industry yearly report; 5 foundation models in bio
 • 
Andrii Buvailo
Why Your Main AI Strategy Should Be Data Connectivity
ALSO: Weekly Highlights; Pick of the Week; Digging Gems of Biopharma
 • 
Andrii Buvailo
Beyond Diagnosis: Digital Pathology's Emerging Role in Drug Development
ALSO: Weekly Highlights; Pick of the Week: the first broadly applicable method to study interactions with proteins in living cells; Digging Gems…
 • 
Andrii Buvailo
Most Popular
View all
The State of A.I. Drug Discovery and Its Future
 • Andrii Buvailo
10 Recent AI in Drug Discovery Highlights
 • Andrii Buvailo
How Technology Enables Better Clinical Trials
 • Andrii Buvailo
AI in Drug Discovery Financing Roundup: Unlearn.AI, Iktos, Ocean Genomics, Genialis, and More
 • Andrii Buvailo
Navigating Data Scarcity: AI's Emerging Role in Biotech
 • Andrii Buvailo
New
Top
Community
Biologics vs. Small Molecules: Who Wins?
ALSO: This Week's Highlights | Pick of the Week: AI for antibody design | Digging Gems: Drug discovery in space; map of preclinical software; and…
 • 
Andrii Buvailo
Navigating Data Scarcity: AI's Emerging Role in Biotech
ALSO: Big pharma hints that AI is already impacting clinical research; Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials; ethical and…
 • 
Andrii Buvailo
10 Recent AI in Drug Discovery Highlights
Notable news about AI in drug discovery, drug developments and biotech to watch; learning about the role of biotech in the U.S. global economy and…
 • 
Andrii Buvailo
"To truly understand a biological system, we must understand its dynamics as any number of factors change"
World's first AI-designed bispecific T cell engager; protein phase separation and novel targets; Dr. Markus Gershater on the Future of AI in Life…
 • 
Andrii Buvailo
AI Foundation Models in Biotech: New Paradigm
The rise of AI foundation models in biotech, companies on the cutting-edge. Biology is a new frontier. Data is still a bottleneck.
 • 
Andrii Buvailo
The Evolution of AI in Drug Discovery Sector
Several studies benchmarking AI adoption in pharma/biotech. Also, reflections on a rapidly changing paradigm of AI in drug discovery.
 • 
Andrii Buvailo
Companies on the Cutting-Edge of Antibiotic Discovery (Tech-enabled)
The looming health crisis; notoriously 'unwanted' business; recent (cool) breakthroughs in antibiotics; how tech may help revive the lost art of…
 • 
Andrii Buvailo
4
The Rise of SynBio in the Era of AI
Stages of AI-driven biologics design; looking at some cutting edge companies merging Synbio with AI -- from gene editing and multi-kilobase RNA editing…
 • 
Andrii Buvailo
How Technology Enables Better Clinical Trials
On artificial intelligence, precision biomarkers, better clinical trials, and a decentralization trend.
 • 
Andrii Buvailo
Where Tech Meets Bio
Where Tech Meets Bio
What does the future hold for us in the “century of biotech“?
Recommendations
View all 6
Decoding Bio
Decoding Bio
Decoding Bio
Data-driven VC
Data-driven VC
Andre Retterath
2-2-2
2-2-2
2-2-2 and NatSec Tech by SCSP
The Century of Biology
The Century of Biology
Elliot Hershberg
People vs Algorithms
People vs Algorithms
Troy Young

Where Tech Meets Bio

AboutArchiveRecommendationsSitemap
© 2023 Andrii Buvailo
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing